China has become the first country to approve a brain implant for commercial sale to treat disabilities. The device, NEO from Neuracle Medical Technology, enables paralyzed individuals to control a robotic hand using their thoughts. This move contrasts with slower progress in clinical trials in the United States and Europe.
China has achieved a milestone in brain-computer interface technology by approving the first commercially available brain chip designed to address disabilities. Developed by Neuracle Medical Technology, the implant named NEO allows users with paralysis to translate their thoughts into movements of an assistive robotic hand. This approval marks China as the pioneering nation in bringing such a device to market for sale, as stated in reports from WIRED published on March 20, 2026. The development highlights China's aggressive push toward commercialization in the sector, while the United States and Europe proceed more cautiously with ongoing clinical trials for similar brain implants. Keywords associated with the story include brain-computer interfaces, neuroscience, and comparisons to companies like Neuralink. This advancement underscores differing regulatory approaches globally, with China aiming to lead the industry, according to the article's title. No specific details on approval timelines or further trials were provided in the source material.
